Haematologic Technologies, Inc. (www.haemtech.com) specializes in manufacturing high quality products for in-vitro coagulation research. Our product line includes: - Plasma-derived coagulation proteins - Antibodies directed against coagulation factors - Factor deficient plasmas - Customized blood collection tubes for clinical research
Looking for a particular Haematologic Technologies, Inc. employee's phone or email?
The Haematologic Technologies, Inc. annual revenue was $1 million in 2026.
Robert Weisman is the CFO of Haematologic Technologies, Inc..
23 people are employed at Haematologic Technologies, Inc..
Haematologic Technologies, Inc. is based in Essex Junction, Vermont.
The NAICS codes for Haematologic Technologies, Inc. are [3254, 325, 32, 32541, 325414].
The SIC codes for Haematologic Technologies, Inc. are [28, 283].